Puma Biotechnology Inc PBYI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/16/21 EDT
10.07UNCH (UNCH)
Volume
20,105
Close
10.07quote price arrow down-0.14 (-1.37%)
Volume
339,398
52 week range
7.48 - 14.14

...

Loading . . .
  • Open10.17
  • Day High10.25
  • Day Low9.87
  • Prev Close10.21
  • 52 Week High14.14
  • 52 Week High Date02/10/21
  • 52 Week Low7.48
  • 52 Week Low Date11/06/20

Key Stats

  • Market Cap405.42M
  • Shares Out40.26M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta1.31
  • YTD % Change-1.85

KEY STATS

  • Open10.17
  • Day High10.25
  • Day Low9.87
  • Prev Close10.21
  • 52 Week High14.14
  • 52 Week High Date02/10/21
  • 52 Week Low7.48
  • 52 Week Low Date11/06/20
  • Market Cap405.42M
  • Shares Out40.26M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta1.31
  • YTD % Change-1.85

RATIOS/PROFITABILITY

  • EPS (TTM)-1.51
  • P/E (TTM)-6.65
  • Fwd P/E (NTM)-14.90
  • EBITDA (MRQ)-20.369M
  • ROE (MRQ)-1,042.30%
  • Revenue (MRQ)225.11M
  • Gross Margin (MRQ)82.51%
  • Net Margin (MRQ)-26.65%
  • Debt To Equity (MRQ)-1,652.01%

EVENTS

  • Earnings Date05/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Puma Biotechnology Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Puma Biotechnology, Inc. is a biopharmaceutical company that focuses on the development and commercialization of products for the treatment of cancer. The Company focuses on in-licensing the development and commercialization rights to over three drug candidates, including PB272 (neratinib, oral), PB272 (neratinib (intravenous)) and PB357. Neratinib is a potent irreversible tyrosine kinase inhibitor (TKI) that blocks signal transduction through the epidermal growth factor...
Alan Auerbach
Chairman
Maximo Nougues
Chief Financial Officer
Address
10880 Wilshire Blvd Ste 2150
Los Angeles, CA
90024-4106
United States

Top Peers

SYMBOLLASTCHG%CHG
ATNX
Athenex Inc
3.97-0.15-3.64%
AKBA
Akebia Therapeutics Inc
2.96-0.10-3.27%
ACOR
Acorda Therapeutics Inc
4.19+0.26+6.62%
CLVS
Clovis Oncology Inc
5.98-0.12-1.97%
SURF
Surface Oncology Inc
6.79-0.37-5.17%